VA Palo Alto Healthcare System, Palo Alto, California, and Stanford University School of Medicine, Stanford, California.
Cedars Sinai Medical Center, Los Angeles, California).
Arthritis Rheumatol. 2015 Nov;67(11):2877-87. doi: 10.1002/art.39283.
Anti-citrullinated protein antibodies (ACPAs) are characteristic of rheumatoid arthritis (RA). However, their presence years before the onset of clinical RA is perplexing. Although multiple putative citrullinated antigens have been identified, no studies have demonstrated the specific capacity of these antigens to initiate inflammatory arthritis. This study was undertaken to recapitulate the transition from preclinical to clinical RA and to demonstrate the capacity of local citrullination to facilitate this transition.
We performed proteomic analysis of activated human neutrophils to identify citrullinated proteins, including those targeted as part of the RA immune response. Using enzyme-linked immunosorbent assay, we compared RA and osteoarthritis synovial fluid for levels of citrullinated histone H2B and its immune complex. Using macrophage activation assays, we assessed the effect of histone citrullination on immunostimulatory capacity and evaluated the stimulatory capacity of native and citrullinated H2B immune complexes. Finally, we assessed the potential for anti-citrullinated H2B antibodies to mediate arthritis in vivo.
We identified robust targeting of neutrophil-derived citrullinated histones by the ACPA immune response. More than 90% of the RA patients had anti-citrullinated H2B antibodies. Histone citrullination increased innate immunostimulatory capacity, and immune complexes containing citrullinated histones activated macrophage cytokine production and propagated neutrophil activation. Finally, we demonstrated that immunization with H2B was arthritogenic, but only in the setting of underlying articular inflammation.
Our findings indicate that citrullinated histones, specifically citrullinated H2B, are an antigenic target of the ACPA immune response. Furthermore, local generation of citrullinated antigen during low-grade articular inflammation provides a mechanistic model for the conversion from preclinical autoimmunity to inflammatory arthritis.
抗瓜氨酸化蛋白抗体(ACPAs)是类风湿关节炎(RA)的特征。然而,它们在临床 RA 发病前多年存在令人费解。虽然已经鉴定出多种假定的瓜氨酸化抗原,但没有研究表明这些抗原具有引发炎症性关节炎的特定能力。本研究旨在再现从临床前到临床 RA 的转变,并证明局部瓜氨酸化促进这种转变的能力。
我们对活化的人中性粒细胞进行蛋白质组学分析,以鉴定瓜氨酸化蛋白,包括作为 RA 免疫反应一部分的靶蛋白。我们使用酶联免疫吸附试验比较 RA 和骨关节炎滑液中瓜氨酸化组蛋白 H2B 及其免疫复合物的水平。我们使用巨噬细胞激活测定法评估组蛋白瓜氨酸化对免疫刺激能力的影响,并评估天然和瓜氨酸化 H2B 免疫复合物的刺激能力。最后,我们评估了抗瓜氨酸化 H2B 抗体在体内介导关节炎的潜力。
我们发现 ACPA 免疫反应强烈靶向中性粒细胞衍生的瓜氨酸化组蛋白。超过 90%的 RA 患者具有抗瓜氨酸化 H2B 抗体。组蛋白瓜氨酸化增加了先天免疫刺激能力,并且包含瓜氨酸化组蛋白的免疫复合物激活了巨噬细胞细胞因子的产生并促进了中性粒细胞的激活。最后,我们证明了用 H2B 免疫是致关节炎的,但仅在关节炎症的背景下。
我们的研究结果表明,瓜氨酸化组蛋白,特别是瓜氨酸化 H2B,是 ACPA 免疫反应的抗原靶标。此外,在低级别关节炎症期间局部产生的瓜氨酸化抗原为从临床前自身免疫到炎症性关节炎的转变提供了一种机制模型。